Iressa Drug Interactions
Currently displaying a list of 235 drugs known to interact with Iressa (gefitinib).
- 38 major drug interactions
- 193 moderate drug interactions
- 4 minor drug interactions
Medications known to interact with Iressa
Note: Showing generic names only.
A
- abametapir topical
- abiraterone
- abrocitinib
- adagrasib
- alpelisib
- aluminum carbonate
- aluminum hydroxide
- aminoglutethimide
- aminolevulinic acid
- aminolevulinic acid topical
- amiodarone
- amobarbital
- amprenavir
- anisindione
- apalutamide
- aprepitant
- aripiprazole
- armodafinil
- asciminib
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atazanavir
- atomoxetine
- avacopan
B
- bedaquiline
- belzutifan
- berotralstat
- bexarotene
- bicalutamide
- binimetinib
- black cohosh
- boceprevir
- bosentan
- brentuximab
- brigatinib
- butabarbital
- butalbital
C
- calaspargase pegol
- calcium carbonate
- cannabidiol
- capivasertib
- carbamazepine
- cenobamate
- ceritinib
- cevimeline
- chloramphenicol
- cimetidine
- ciprofloxacin
- clarithromycin
- clofarabine
- clotrimazole
- cobicistat
- codeine
- conivaptan
- crizotinib
- cyclosporine
D
- dabrafenib
- daclizumab
- dacomitinib
- danazol
- darifenacin
- darunavir
- dasatinib
- deferasirox
- delavirdine
- dexamethasone
- dexlansoprazole
- dicumarol
- dihydroxyaluminum sodium carbonate
- diltiazem
- donepezil
- dronedarone
- duloxetine
- duvelisib
E
- echinacea
- efavirenz
- elafibranor
- elagolix
- encorafenib
- entrectinib
- enzalutamide
- epirubicin
- erythromycin
- eslicarbazepine
- esomeprazole
- etranacogene dezaparvovec
- etravirine
F
- famotidine
- fedratinib
- felbamate
- fesoterodine
- fexinidazole
- fidanacogene elaparvovec
- fluconazole
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fosphenytoin
- fostamatinib
G
I
- idelalisib
- imatinib
- indinavir
- interferon beta-1a
- interferon beta-1b
- isavuconazonium
- isoniazid
- itraconazole
- ivacaftor
- ivosidenib
K
L
- lansoprazole
- lapatinib
- larotrectinib
- lefamulin
- leflunomide
- lenacapavir
- lesinurad
- letermovir
- levoketoconazole
- lomitapide
- lonafarnib
- lonapegsomatropin
- lorlatinib
- lusutrombopag
M
- magaldrate
- magnesium carbonate
- magnesium hydroxide
- magnesium oxide
- mavacamten
- mavorixafor
- mephobarbital
- methotrexate
- methoxsalen
- methyl aminolevulinate topical
- metreleptin
- mibefradil
- miconazole
- mifepristone
- mipomersen
- mitapivat
- mitotane
- mobocertinib
- modafinil
N
O
P
- pacritinib
- palbociclib
- pantoprazole
- pazopanib
- pegaspargase
- peginterferon beta-1a
- pentobarbital
- pexidartinib
- phenobarbital
- phenylbutazone
- phenytoin
- pirtobrutinib
- pitolisant
- posaconazole
- pralsetinib
- primidone
R
- rabeprazole
- ranitidine
- ranitidine bismuth citrate
- ranolazine
- remdesivir
- repotrectinib
- ribociclib
- rifabutin
- rifampin
- rifapentine
- riociguat
- ritlecitinib
- ritonavir
- rucaparib
- rufinamide
S
- saquinavir
- secobarbital
- selpercatinib
- sodium bicarbonate
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- st. john's wort
- sulfinpyrazone
T
- talazoparib
- tazemetostat
- tecovirimat
- telaprevir
- telithromycin
- telotristat
- teriflunomide
- thioguanine
- thioridazine
- timolol ophthalmic
- tolterodine
- tovorafenib
- trabectedin
- trofinetide
- troglitazone
- troleandomycin
- tucatinib
U
V
- valoctocogene roxaparvovec
- vemurafenib
- verapamil
- verteporfin
- viloxazine
- vonoprazan
- voriconazole
- voxelotor
W
Z
Iressa disease interactions
There are 6 disease interactions with Iressa (gefitinib) which include:
- dermatologic toxicities
- GI disorders
- ocular disorders
- pulmonary toxicity
- liver disease
- renal dysfunction
More about Iressa (gefitinib)
- Iressa consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.